跳转至内容
Merck
CN

880180P

Avanti

C16 PEG2000神经酰胺

Avanti Research™ - A Croda Brand

别名:

N-棕榈酰-鞘氨醇-1-{琥珀酰[甲氧基(聚乙二醇)2000]}

登录查看公司和协议定价

选择尺寸

关于此项目

化学文摘社编号:
212116-78-4
UNSPSC代码:
12352211
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

C16 PEG2000神经酰胺, Avanti Research™ - A Croda Brand 880180P, powder

方案

>99% (TLC)

表单

powder

包装

pkg of 1 × 1 g (880180P-1g)
pkg of 1 × 200 mg (880180P-200mg)
pkg of 1 × 25 mg (880180P-25mg)
pkg of 1 × 500 mg (880180P-500mg)

制造商/商品名称

Avanti Research™ - A Croda Brand 880180P

运输

dry ice

储存温度

−20°C

SMILES字符串

[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O.C=C

InChI

1S/C127H249NO51.C2H4/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-124(129)123(128-125(130)31-29-27-25-23-21-19-17-15-13-11-9-7-5-2)122-177-126(131)32-33-127(132)179-178-121-120-176-119-118-175-117-116-174-115-114-173-113-112-172-111-110-171-109-108-170-107-1

InChI key

GOLNQGXRLCYSCW-UNBRHOPNSA-N

相关类别

一般描述

C16 PEG2000神经酰胺，也称为N-棕榈酰-鞘氨醇-1-{琥珀酰[甲氧基(聚乙二醇)2000]}，是一种聚乙二醇(PEG)化神经酰胺。

应用

C16 PEG2000神经酰胺或N-棕榈酰-鞘氨醇-1-{琥珀酰[甲氧基(聚乙二醇)2000]}已用于制备类脂质/蛋白纳米复合体。还用于制备SNALP（稳定核酸脂质颗粒）。

包装

20 mL螺旋盖透明玻璃小瓶(880180P-1g)
20 mL螺旋盖透明玻璃小瓶(880180P-500mg)
5 mL螺旋盖棕色玻璃小瓶(880180P-200mg)
5 mL螺旋盖棕色玻璃小瓶(880180P-25mg)

法律信息

Avanti Research is a trademark of Avanti Polar Lipids, LLC

储存分类代码

11 - Combustible Solids

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Kaushik Thanki et al.
Pharmaceutical research, 36(3), 37-37 (2019-01-10)
Antisense oligonucleotides (ASOs) are promising therapeutics for specific modulation of cellular RNA function. However, ASO efficacy is compromised by inefficient intracellular delivery. Lipid-polymer hybrid nanoparticles (LPNs) are attractive mediators of intracellular ASO delivery due to favorable colloidal stability and sustained
Kaushik Thanki et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 120, 22-33 (2017-08-02)
Safety and efficacy of therapeutics based on RNA interference, e.g., small interfering RNA (siRNA), are dependent on the optimal engineering of the delivery technology, which is used for intracellular delivery of siRNA to the cytosol of target cells. We investigated
Xiaoying Wang et al.
Journal of controlled release : official journal of the Controlled Release Society, 263, 39-45 (2017-02-06)
Developing safe and effective nanosystems to deliver active and therapeutic proteins to targeted cells and organs is an important tool for many biomedical applications. We present here a simple and efficient strategy for this purpose: delivering hyaluronic acid (HA)-modified RNase

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持